Eight markers, i.e. plasma IL-1β, IL-6, IL-12p70, and fecal CgA, calprotectin, HBD2, valerate, and caproate, proved to be significantly altered in IBS patients compared to HC, when tested by univariate analyses (Table 2). The gene discussed is IL6; the disease is irritable bowel syndrome.